Whitney & Company »

Altimmune shares owned by Whitney & Company

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Whitney & Company from 13F filings

Historical chart of Whitney & Company investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Whitney & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Whitney & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.4k 26k 0.33

More positions owned by Whitney & Company

Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ishares Tr Core S&p Ttl Stk (ITOT)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Doubleline Etf Trust Opportunistic Co (DBND)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Charles Schwab Corporation (SCHW)
Visa Com Cl A (V)

View all positions for Whitney & Company

Top funds holding Altimmune

Vanguard Group
BlackRock
Susquehanna International
State Street Corporation
Tang Capital Management
Citadel Advisors
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Knoll Capital Management
Ikarian Capital
UBS Group
Morgan Stanley
Northern Trust
Squarepoint Ops

View all funds holding Altimmune